
Daqing Huake Company Limited, founded in 1998 and headquartered in Daqing, China, operates primarily in the chemical sector within the country. The company specializes in the research, manufacturing, and distribution of petrochemicals and various fine chemical products. Its extensive chemical offerings include heavy and light aromatics, crude compounds such as isopentene, isoprene, and pentadiene, industrial acetonitrile, dicyclopentadiene, ethylene tar, hydrogenated pentene, light-colored petroleum resins, and intermittent liquid-phase bulk polypropylene powder. Beyond chemicals, Daqing Huake also produces a range of plastic items, notably specialized polypropylene materials for woven bag coatings and polyethylene insulation for communication cables, as well as a selection of medical and health-related goods. The company maintains an international presence, exporting its diverse product lines to approximately 20 countries and regions worldwide, including significant markets in Europe, Southeast Asia, and North America.
Daqing Huake Company Limited trades as 000985.SZ on SHZ. The company is classified in Basic Materials / Chemicals and reports in CNY.
The current profile places the business in Chemicals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Daqing Huake Company Limited can be compared against peers such as Maoming Petro-Chemical Shihua Co., Ltd, Anhui Annada Titanium Industry Co., Ltd., Wuxi Honghui New Materials Technology Co., Ltd., Zhejiang Dayang Biology Technology Co.,Ltd., Changzhou Tiansheng New Materials Co., Ltd., Henan Qingshuiyuan Technology CO.,Ltd.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $2.12B, beta of 0.63, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
000985.SZ currently shows total debt of N/A and beta of 0.63. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.huake.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.